TABLE 3.
Virus types mixed | Ratio of types in mix | Amount of product (percentage of pixels ± SD) from type:
|
||
---|---|---|---|---|
1 | 2 | 3 | ||
1 and 2 | 90:10 | 48.7 ± 5.0 | 51.2 ± 5.0 | |
50:50 | 30.0 ± 3.3 | 70.0 ± 3.3 | ||
10:90 | 12.7 ± 7.5 | 87.2 ± 7.5 | ||
1 and 3 | 90:10 | 53.3 ± 12.1 | 46.7 ± 12.1 | |
50:50 | 53.7 ± 15.6 | 46.2 ± 15.6 | ||
10:90 | 25.2 ± 5.1 | 74.8 ± 5.1 | ||
2 and 3 | 90:10 | 90.5 ± 4.1 | 9.5 ± 4.1 | |
50:50 | 73.7 ± 8.2 | 26.2 ± 8.2 | ||
10:90 | 59.7 ± 8.7 | 40.3 ± 8.7 |
Data shown are the averages of results from six (for mixtures of types 1 and 3 and 2 and 3) or eight (for mixture of types 1 and 2) independent experiments with 13 viremic serum samples. MMLV reverse transcriptase and 5′ UTR primer sets 1 and 2 were used for experiments. Reverse transcription performed by using Tth reverse transcriptase with another batch of five serum samples (not described in this study) rendered similar results. P values for comparisons between product ratios were as follows: for types 1 and 2 versus types 2 and 3, <0.0001 with all mix ratios; for types 1 and 2 versus types 1 and 3, not significant with a 90:10 mix ratio, 0.0060 with a 50:50 mix ratio, and 0.0044 with a 10:90 mix ratio; for types 2 and 3 versus types 1 and 3, <0.0001 with 90:10 and 10:90 mix ratios and not significant with a 50:50 mix ratio.